References
- Stein JP Lie skovsky G Cote R Groshen S Feng AC Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666–75.
- Sanchez-Ortiz RF Huang WC Mick R Van Arsdalen KN Wein AJ Malkowicz SB. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 2003; 169: 110–5, discussion 115.
- Madersbacher S Hochreiter W Burkhard F Thalmann GN Danuser H Studer TIE. Radical cystectomy for bladder cancer today—a homogeneous series without neoadju-vant therapy. J Clin Oncol 2003; 21: 690–6.
- Slaton JW Swanson DA Grossman BB Dinney CP. A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 1999; 162: 710–4.
- Juffs HG Moore MJ Tannock IF. The role of systemic chemotherapy in the management of muscle-invasive bladder cancer [Review]. Lancet Oncol 2002; 3: 738–47.
- Segal R Winquist E Lukka H Chin JL Brundage M Markman BR, et al. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma—a practice guideline. Can J Urol 2002; 9: 1625–33.
- Sherif A Rintala E Mestad 0 Nilsson J Holmberg L Nilsson S, et al. Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer—Nordic cystectomy trial 2. Scand J Urol Nephrol 2002; 36: 419–25.
- Hara I Miyake H Hara S Gotoh A Okada H Arakawa S, et al. Optimal timing of radical cystectomy for patients with invasive transitional cell carcinoma of the bladder. Jpn J Clin Oncol 2002; 32: 14–8.
- Hautmann RE Paiss T. Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy? J Urol 1998; 159: 1845–50.
- Newling DW. Preventing recurrence and progression in superficial bladder cancer. Curr Opin Urol 1996; 6: 272–5.
- Konety BR Joslyn SA O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 2003; 169: 946–50.